Morgan Stanley’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9B Sell
44,721,167
-1,604,422
-3% -$374M 0.66% 20
2025
Q4
$9.59B Sell
46,325,589
-1,906,078
-4% -$377M 0.57% 19
2025
Q3
$8.94B Buy
48,231,667
+1,246,800
+3% +$214M 0.54% 23
2025
Q2
$7.18B Buy
46,984,867
+954,178
+2% +$147M 0.47% 29
2025
Q1
$7.63B Buy
46,030,689
+2,121,249
+5% +$332M 0.55% 28
2024
Q4
$6.35B Sell
43,909,440
-1,252,689
-3% -$194M 0.44% 32
2024
Q3
$7.32B Buy
45,162,129
+3,092,860
+7% +$493M 0.53% 28
2024
Q2
$6.15B Sell
42,069,269
-480,674
-1% -$71.5M 0.48% 30
2024
Q1
$6.73B Sell
42,549,943
-40,769,015
-49% -$6.49B 0.54% 26
2023
Q4
$13.1B Buy
83,318,958
+42,073,857
+102% +$6.45B 0.58% 25
2023
Q3
$6.42B Sell
41,245,101
-424,118
-1% -$70M 0.65% 19
2023
Q2
$6.9B Buy
41,669,219
+1,665,699
+4% +$269M 0.68% 16
2023
Q1
$6.2B Sell
40,003,520
-2,221,001
-5% -$359M 0.66% 16
2022
Q4
$7.46B Buy
42,224,521
+4,521,062
+12% +$781M 0.85% 9
2022
Q3
$6.16B Sell
37,703,459
-212,552
-0.6% -$36M 0.84% 8
2022
Q2
$6.73B Buy
37,916,011
+11,903,316
+46% +$2.12B 0.87% 8
2022
Q1
$4.61B Buy
26,012,695
+258,860
+1% +$44M 0.62% 20
2021
Q4
$4.41B Buy
25,753,835
+857,814
+3% +$140M 0.54% 25
2021
Q3
$4.02B Sell
24,896,021
-170,723
-0.7% -$29.1M 0.54% 29
2021
Q2
$4.13B Buy
25,066,744
+760,796
+3% +$126M 0.54% 29
2021
Q1
$3.99B Buy
24,305,948
+194,920
+0.8% +$31.5M 0.59% 24
2020
Q4
$3.79B Buy
24,111,028
+1,638,263
+7% +$242M 0.59% 28
2020
Q3
$3.35B Buy
22,472,765
+933,976
+4% +$138M 0.65% 27
2020
Q2
$3.03B Buy
21,538,789
+737,356
+4% +$107M 0.67% 23
2020
Q1
$2.73B Buy
20,801,433
+54,563
+0.3% +$7.74M 0.74% 17
2019
Q4
$3.03B Buy
20,746,870
+1,165,291
+6% +$158M 0.7% 13
2019
Q3
$2.53B Sell
19,581,579
-413,488
-2% -$54.5M 0.67% 14
2019
Q2
$2.78B Buy
19,995,067
+122,033
+0.6% +$16.9M 0.74% 12
2019
Q1
$2.78B Sell
19,873,034
-2,443,609
-11% -$327M 0.79% 10
2018
Q4
$2.88B Sell
22,316,643
-603,827
-3% -$84.2M 0.86% 8
2018
Q3
$3.17B Buy
22,920,470
+1,352,484
+6% +$180M 0.79% 10
2018
Q2
$2.62B Sell
21,567,986
-215,802
-1% -$26.9M 0.71% 12
2018
Q1
$2.79B Buy
21,783,788
+246,369
+1% +$33.3M 0.77% 9
2017
Q4
$3.01B Buy
21,537,419
+971,757
+5% +$135M 0.82% 9
2017
Q3
$2.67B Sell
20,565,662
-1,030,192
-5% -$137M 0.8% 9
2017
Q2
$2.86B Buy
21,595,854
+1,947,349
+10% +$248M 0.86% 8
2017
Q1
$2.45B Sell
19,648,505
-1,479,379
-7% -$177M 0.75% 11
2016
Q4
$2.43B Buy
21,127,884
+1,440,608
+7% +$166M 0.8% 10
2016
Q3
$2.33B Buy
19,687,276
+256,409
+1% +$31.1M 0.79% 10
2016
Q2
$2.36B Buy
19,430,867
+1,277,146
+7% +$145M 0.85% 7
2016
Q1
$1.96B Sell
18,153,721
-880,617
-5% -$91.2M 0.76% 8
2015
Q4
$1.96B Buy
19,034,338
+3,005,352
+19% +$302M 0.71% 9
2015
Q3
$1.5B Sell
16,028,986
-1,235,559
-7% -$120M 0.55% 13
2015
Q2
$1.68B Buy
17,264,545
+760,241
+5% +$76.1M 0.58% 14
2015
Q1
$1.66B Sell
16,504,304
-705,084
-4% -$71.7M 0.61% 13
2014
Q4
$1.8B Buy
17,209,388
+2,190,611
+15% +$231M 0.66% 12
2014
Q3
$1.6B Buy
15,018,777
+1,034,818
+7% +$107M 0.62% 11
2014
Q2
$1.46B Buy
13,983,959
+374,149
+3% +$37.8M 0.57% 14
2014
Q1
$1.34B Sell
13,609,810
-1,586,082
-10% -$147M 0.56% 15
2013
Q4
$1.39B Buy
15,195,892
+1,501,715
+11% +$138M 0.59% 14
2013
Q3
$1.19B Buy
13,694,177
+239,164
+2% +$21.5M 0.56% 15
2013
Q2
$1.16B Buy
+13,455,013
New +$1.14B 0.58% 15

Other funds holding JNJ

Morgan Stanley's JNJ Position: Q1 2026 in Review

Morgan Stanley reduced its Johnson & Johnson (JNJ) stake by 3.5% in Q1 2026, selling an estimated $374M and leaving 44,721,167 shares worth $10.9B. The position accounts for 0.66% of the portfolio, ranked #20.

Morgan Stanley first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1B in Q4 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Morgan Stanley held 44,721,167 shares of Johnson & Johnson worth $10.9B as of Q1 2026.
  • Morgan Stanley sold 1,604,422 Johnson & Johnson shares in Q1 2026, an estimated $374M.
  • Johnson & Johnson made up 0.66% of Morgan Stanley's portfolio in Q1 2026, its #20 holding.
  • Morgan Stanley first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Johnson & Johnson position peaked at $13.1B in Q4 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.